Profile - Genentech, Inc. The Company manufactures and markets nine protein-based pharmaceuticals and licenses several additional products to other companies. In general, the Company's products are sold to distributors, or directly to hospital pharmacies or medical centers. Revenues reflect increased sales of Rituxan and Herceptin.
Net income reflects a decrease in the cost of sales.
All Rights Reserved. Privacy Policy - Terms of Service Company information Copyright Market Guide . Some event data provided by StreetEvents . Data and information is provided for informational purposes only, and is not intended for trading purposes.